Spark Hope for those with Neuroendocrine Tumors
Your gift can help improve, extend, and save lives
Patient Resources
NETRF Recognized as Top-Tier Charity
NETRF’s strong financial position, transparency, and accountability again earned it a 4-star rating by Charity Navigator, a national evaluator of nonprofits. The 4-star rating indicates the utmost in fiscal responsibility, ethical practices, and governance.
News & Updates
“Getting it All”
October 16, 2018Early Research on Targeting Single Cancer Cells to Prevent Metastasis Despite the effectiveness of Peptide Receptor Radionuclide Therapy (PRRT) to prolong survival of those with neuroendocrine tumors (NETs), many patients will see their cancer spread a
CarGurus Makes Grant to NETRF
October 16, 2018The Neuroendocrine Tumor Research Foundation (NETRF) gratefully received a $35,000 donation for NET research from the CarGurus Charitable Giving Fund. NETRF was nominated by a CarGurus employee to receive a grant and this grant was one
New Grant Explores Novel Drug Delivery System
October 15, 2018Antibody-drug conjugate aims to combine the benefits of targeted therapy and chemotherapy (Left to right) Elyse Gellerman, NETRF CEO; Renata Jaskula-Sztula, PhD, NANETS/NETRF BTSI Investigator; Effie Tzameli, PhD, NETRF Director of Research. Renata Jaskula-Sztul, PhD, Assistant
